Carey Fineman Ziter syndrome

From WikiMD's Medical Encyclopedia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Carey-Fineman-Ziter syndrome
Synonyms
Pronounce
Specialty Medical genetics
Symptoms Facial weakness, myopathy, Pierre Robin sequence, scoliosis, delayed motor development
Complications N/A
Onset
Duration
Types
Causes Mutations in the MYMK gene
Risks
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis
Prevention
Treatment Supportive care, physical therapy, speech therapy
Medication
Prognosis
Frequency Very rare
Deaths


Carey Fineman Ziter syndrome is a rare congenital disorder characterized by a combination of distinctive facial features, intellectual disability, and physical abnormalities. The syndrome was first described in 1982 by Dr. David Carey, Dr. Michael Fineman, and Dr. Robert Ziter.

Symptoms and Signs[edit]

The most common features of Carey Fineman Ziter syndrome include microcephaly (small head size), hypotonia (low muscle tone), myopathy (muscle weakness), ptosis (drooping of the upper eyelid), and distinctive facial features such as a high forehead, long face, and prominent chin. Intellectual disability is also common, and can range from mild to severe. Other features can include feeding difficulties, respiratory problems, and skeletal abnormalities.

Causes[edit]

Carey Fineman Ziter syndrome is caused by mutations in the MYMK gene. This gene provides instructions for making a protein that is involved in the development and function of muscles. Mutations in the MYMK gene disrupt the normal development and function of muscles, leading to the characteristic features of Carey Fineman Ziter syndrome.

Diagnosis[edit]

Diagnosis of Carey Fineman Ziter syndrome is based on the presence of characteristic clinical features. Genetic testing can confirm the diagnosis by identifying a mutation in the MYMK gene.

Treatment[edit]

There is currently no cure for Carey Fineman Ziter syndrome. Treatment is supportive and based on the signs and symptoms present in each individual. This can include physical therapy for muscle weakness, special education services for intellectual disability, and management of respiratory problems.

Prognosis[edit]

The prognosis for individuals with Carey Fineman Ziter syndrome varies depending on the severity of symptoms. Some individuals may have a normal lifespan, while others may have a shortened lifespan due to complications such as respiratory problems.

See Also[edit]

References[edit]

NIH genetic and rare disease info[edit]

Carey Fineman Ziter syndrome is a rare disease.







This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.